Copyright: Jacobio Pharmaceuticals Co., Ltd.   Beijing ICP preparation 17065868-1   

 

百度地图API自定义地图

Address: Building F2, No. 88, Kechuang 6th Street, Beijing Economic Development Zone

Tel: +86  010-56315466

Fax: +86  010-56315314

E-mail: hr@jacobiopharma.com

 

 

关于我们

NEW

NEW

JAB-3312, Jacobio’s Second Innovative Drug, has Obtained FDA’s Approval for Clinical Study
Jacobio's Innovative Drug Approved for Phase IIa Clinical Study in Multiple Solid Tumors and Awarded Orphan Drug Designation for the Treatment of Esophageal Cancer by US FDA
Jacobiopharma won the Zhongguancun high tech Enterprises
Jacobio post doctoral research workstation was set up
JAB-3068 Clinical Program Discussion Meeting Successfully Held
Page up
1